Procter & Gamble (PG) EBITDA (2009 - 2026)

Procter & Gamble (PG) has reported EBITDA for 18 consecutive years, with $4.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 9.3% year-over-year to $4.0 billion in Q2 2026; TTM through Jun 2026 was $19.7 billion, a 3.44% decrease from a year earlier, with the FY2026 full-year figure at $19.7 billion, down 3.44% from the prior year.
• EBITDA was $4.0 billion for Q2 2026 at Procter & Gamble, down from $4.6 billion in the prior quarter.
• Over five years, EBITDA peaked at $5.9 billion in Q3 2025 and troughed at $3.6 billion in Q2 2022.
• A 5-year average of $4.7 billion and a median of $4.5 billion in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA rose 29.51% in 2024 and declined 9.3% in 2026, its largest moves.
• Over 5 years, EBITDA stood at $4.8 billion in 2022, then decreased by 7.36% to $4.4 billion in 2023, then gained by 29.51% to $5.7 billion in 2024, then decreased by 6.53% to $5.4 billion in 2025, then dropped by 26.39% to $4.0 billion in 2026.
• The last three EBITDA figures came in at $4.0 billion (Q2 2026), $4.6 billion (Q1 2026), and $5.4 billion (Q4 2025), per Business Quant data.